Correlates of T-cell-mediated viral control and phenotype of CD8(+) T cells in HIV-2, a naturally contained human retroviral infection.
While a significant proportion of HIV-2-infected individuals are asymptomatic and maintain undetectable viral loads (controllers), 15% to 20% progress to AIDS and are predicted by detectable viremia. Identifying immune correlates that distinguish these 2 groups should provide insights into how a potentially pathogenic retrovirus can be naturally controlled. We performed a detailed study of HIV-2-specific cellular responses in a unique community cohort in Guinea-Bissau followed for over 2 decades. T-cell responses were compared between controllers (n = 33) and viremic subjects (n = 27) using overlapping peptides, major histocompatibility complex class I tetramers, and multiparameter flow cytometry. HIV-2 viral control was significantly associated with a high-magnitude, polyfunctional Gag-specific CD8(+) T-cell response but not with greater perforin upregulation. This potentially protective HIV-2-specific response is surprisingly narrow. HIV-2 Gag-specific CD8(+) T cells are at an earlier stage of differentiation than cytomegalovirus-specific CD8(+) T-cells, do not contain high levels of cytolytic markers, and exhibit low levels of activation and proliferation, representing distinct properties from CD8(+) T cells associated with HIV-1 control. These data reveal the potential T-cell correlates of HIV-2 control and the detailed phenotype of virus-specific CD8(+) T cells in a naturally contained retroviral infection.
Item Type | Article |
---|---|
Keywords | hla class-i, disease progression, guinea-bissau, responses, virus, aids, expression, survival, women, load, Adult, Aged, Aged, 80 and over, Anti-Retroviral Agents, therapeutic use, Antigens, CD, metabolism, CD8-Positive T-Lymphocytes, cytology, immunology, metabolism, virology, Cell Differentiation, immunology, Cell Proliferation, Female, Flow Cytometry, GPI-Linked Proteins, metabolism, HIV Infections, drug therapy, immunology, HIV-2, immunology, Humans, Immunophenotyping, Male, Middle Aged, Programmed Cell Death 1 Receptor, metabolism, Receptors, Immunologic, metabolism, Viremia, drug therapy, immunology, gag Gene Products, Human Immunodeficiency Virus, immunology |
ISI | 321873900016 |
Date Deposited | 23 Sep 2013 19:28 |